BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24198226)

  • 1. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.
    Lahuerta M; Wu Y; Hoffman S; Elul B; Kulkarni SG; Remien RH; Nuwagaba-Biribonwoha H; El-Sadr W; Nash D; ;
    Clin Infect Dis; 2014 Feb; 58(3):432-41. PubMed ID: 24198226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.
    Nash D; Wu Y; Elul B; Hoos D; El Sadr W;
    AIDS; 2011 Jul; 25(12):1523-33. PubMed ID: 21750418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013.
    Nash D; Tymejczyk O; Gadisa T; Kulkarni SG; Hoffman S; Yigzaw M; Elul B; Remien RH; Lahuerta M; Daba S; El Sadr W; Melaku Z
    J Int AIDS Soc; 2016; 19(1):20637. PubMed ID: 27113335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
    Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
    PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011.
    Hoffman S; Wu Y; Lahuerta M; Kulkarni SG; Nuwagaba-Biribonwoha H; Sadr WE; Remien RH; Mugisha V; Hawken M; Chuva E; Nash D; Elul B;
    AIDS; 2014 Oct; 28(16):2429-38. PubMed ID: 25136842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of HIV-Infected Children at Enrollment into Care and at Antiretroviral Therapy Initiation in Central Africa.
    Adedimeji A; Edmonds A; Hoover D; Shi Q; Sinayobye JD; Nduwimana M; Lelo P; Nash D; Anastos K; Yotebieng M
    PLoS One; 2017; 12(1):e0169871. PubMed ID: 28081230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 9. Longitudinal analysis of sociodemographic, clinical and therapeutic factors of HIV-infected individuals in Kinshasa at antiretroviral therapy initiation during 2006-2017.
    Ngongo NM; Darcis G; Nanituna HS; Mambimbi MM; Maes N; Mashi ML; Bepouka Izizag B; Moutschen M; Lepira Bompeka F
    PLoS One; 2021; 16(11):e0259073. PubMed ID: 34739506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
    Geng EH; Hunt PW; Diero LO; Kimaiyo S; Somi GR; Okong P; Bangsberg DR; Bwana MB; Cohen CR; Otieno JA; Wabwire D; Elul B; Nash D; Easterbrook PJ; Braitstein P; Musick BS; Martin JN; Yiannoutsos CT; Wools-Kaloustian K
    J Int AIDS Soc; 2011 Sep; 14():46. PubMed ID: 21955541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria.
    Aliyu MH; Blevins M; Parrish DD; Megazzini KM; Gebi UI; Muhammad MY; Ahmed ML; Hassan A; Shepherd BE; Vermund SH; Wester CW
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):e41-9. PubMed ID: 23727981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
    May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
    Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries.
    Eduardo E; Lamb MR; Kandula S; Howard A; Mugisha V; Kimanga D; Kilama B; El-Sadr W; Elul B
    PLoS One; 2014; 9(7):e103864. PubMed ID: 25075743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care.
    Lamb MR; Fayorsey R; Nuwagaba-Biribonwoha H; Viola V; Mutabazi V; Alwar T; Casalini C; Elul B
    AIDS; 2014 Feb; 28(4):559-68. PubMed ID: 24076661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis.
    Siedner MJ; Ng CK; Bassett IV; Katz IT; Bangsberg DR; Tsai AC
    Clin Infect Dis; 2015 Apr; 60(7):1120-7. PubMed ID: 25516189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.
    Ambia J; Renju J; Wringe A; Todd J; Geubbels E; Nakiyingi-Miiro J; Urassa M; Lutalo T; Crampin AC; Kwaro D; Kyobutungi C; Chimbindi N; Gomez-Olive FX; Tlhajoane M; Njamwea B; Zaba B; Mee P
    BMC Health Serv Res; 2017 Nov; 17(1):758. PubMed ID: 29162065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
    Tymejczyk O; Brazier E; Yiannoutsos CT; Vinikoor M; van Lettow M; Nalugoda F; Urassa M; Sinayobye JD; Rebeiro PF; Wools-Kaloustian K; Davies MA; Zaniewski E; Anderegg N; Liu G; Ford N; Nash D;
    PLoS Med; 2019 Jun; 16(6):e1002822. PubMed ID: 31181056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.